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 Abstract 
Knowledge of the interactome improves the understanding 
of disease metabolism. Biological information about 
interactions among genes and their protein products, 
computationally extracted in the context of SysBiomics, can 
hint at molecular causes of diseases, be essential for 
understanding biological systems, and provide clues for new 
therapeutic approaches. Quick and efficient access to this 
data have become critical issues for biologists. We have 
implemented a computational platform that integrates 
pathway, protein–protein interaction, differentially 
expressed genome and literature mining data to result in 
comprehensive networks for insomnia and intervention 
effects of Jujuboside B (JuB). The interaction data were 
imported into Cytoscape software, a popular bioinformatics 
package for biological network visualization and data 
integration, for screening the central nodes of the network, 
exploiting functional study of the central node genes, 
exploring the mechanism of insomnia. Results showed that 
seven differentially expressed genes confirmed by Cytoscape 
as the central nodes of the network in insomnia had 
interactions, forming a complicated interaction network (77 
nodes, 96 edges). Among gene nodes, HBA1, LEP, MAOA, 
PRNP, GHRL, CLOCK and SLC6A4 were verified as the genes 
with maximal differential expressions. Of note, we further 
observed that the HBA1, LEP, SLC6A4 and MAOA were JuB 
target genes. The interaction network of the differentially 
expressed genes, especially the central nodes of this 
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network, can provide clues to the insomnia, early diagnosis 
and molecular targeted therapy. Our findings demonstrate 
that the integration of interaction network in genomic space 
can not only speed the genome-wide identification of drug 
targets but also find new applications for the existing drugs. 
Keywords: Interaction network; network pharmacology; 
Jujuboside B; insomnia; targets; differentially expressed genes 
Introduction 
SysBiomics approach seeks to comprehend the 
complexity of organisms by combining many different 
kinds of data (protein-protein and protein-DNA 
interactions, protein modifications, biochemistry, etc.) to 
create predictive models. In the era of SysBiomics, the 
focus on understanding complex organisms is shifting 
from studying individual genes and proteins towards the 
relationships between them (Gilchrist et al., 2006; 
Hopkins, 2008). These relationships are usually expressed 
in terms of various kinds of biological networks. Network 
among biomolecules is an intensive field of research in 
SysBiomics. Molecular interactions are the focus of many 
functional genomics studies, and they form a cornerstone 
of Systems biology research. Network models can reveal 
complex relationships in large data sets, and network 
topologies have been shown to share remarkably 
consistent features across diverse fields. Many studies 
have reported interesting biological findings from these 
networks, including the relationships between various 
statistical properties of a gene and its function at the 
molecular level based on networks (Tamble et al., 2011). 
Network pharmacology can make an impact at several 
points in the drug-development process: target 
identification, lead discovery and optimization, preclinical 
efficacy and safety assessment, and mode-of-action. 
Network diagrams are used for visualizing and 
understanding these interactions, interpreting 
high-throughput experimental data, generating hypotheses 
and sharing results (Zou, Luo, Wei, & Yang, 2011). 
Increasing complexity of functional genomics data drives 
the development of methods and tools for data integration 
and visualization (Wu, Jiang, Zhang, & Li, 2008).  
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The most widely used open source network 
visualization workbench is Cytoscape which has greatly 
extended the reach of genomic research (Shannon et al., 
2003). Data from various sources can be imported into this 
tool to build networks, and to highlight specific node or 
edge features. Cytoscape software (Fig. 1), a web-based 
network visualization tool, is an open-source software 
platform for visualizing molecular interaction networks 
and integrating these interactions with gene expression 
profiles and other functional genomics data. By providing 
platforms to integrate data with molecular interaction 
networks, researchers can more rapidly begin 
interpretation of large data sets collected for a system of 
interest. Currently, the network model is based on genes, 
proteins and functional relationships between them such 
as protein-protein, protein-DNA regulatory interactions 
and gene-protein coding relationship (Cline et al., 2007).  
Disease gene prediction is one of the most important 
 
Fig. 1. Cytoscape version 2.8 shows a randomization instance of an integrated 
 
Fig. 2. Chemical structure of Jujuboside B 
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aims in biological and medical sciences. Network 
pharmacology has become more and more attractive in the 
research field of disease-causing gene discovery. 
Researchers attach great importance to special features 
embedded in biological networks especially the interaction 
network for deeply understanding molecular mechanism 
of common human diseases (Zhang, Shi, Duncan, 
Prodduturi, Marnett, & Liebler, 2011; Yao, Hao, Li, & Li, 
2011). Network reconstruction of biological entities is very 
important for understanding biological systems. Together 
with network pharmacology, this preliminary study is one 
step toward genome-wide drug target identification. Until 
recently however, the analysis of insomnia network and its 
influence on disease-gene discovery are still unaddressed 
and insomnia model systems had little interaction data 
available. 
Insomnia is a serious health problem, and enhancing 
sleep quality is an issue of significant importance to public 
health. Recently, it is estimated that more than one-third 
people in the world suffer from insomnia and frequently 
occurs at a rate of approximately 10 per cent in many 
countries and that causes a worldwide disease burden 
(Mahowald & Schenck, 2005). Concerning sleep quality, 
25.3% of the general population was dissatisfied with their 
sleep (Vecsey et al., 2009; Richey & Krystal, 2011). 
Sedative-hypnotic drugs are increasingly prescribed for 
 
 
Fig. 3. Interaction network (Circle Layout) of the differentially expressed genes in 
 insomnia using the Cytoscape 
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the insomniac patients, reflect the higher prevalence of 
anxiety and sleep disorders. However, a variety of 
problems, such as alteration of sleep structure, tolerance 
of the hypnosedative effects, pharmacological dependence, 
cognitive and psychomotor impairment, abuse potential 
and respiratory depression of these medications have 
drawn much attention. A growing body of evidence now 
suggests that these drugs do not exert satisfactory 
therapeutic effects (Sarris & Byrne, 2011). The outlook is 
worsened by the absence of promising drug targets for this 
disease. Currently, a paradigm shift is occurring in that 
there is a new focus on the pursuit of new drug targets due 
to an urgent need for new drugs for the treatment of 
insomnia. More and more evidence supports that many 
Chinese medicinal products have been used for the 
treatment of insomnia and their therapeutic effects have 
also been verified by a host of clinical studies. Amusingly, a 
number of steroidlike compounds, such as triterpenoids, 
steroids and saponins, found in many Chinese medicinal 
products are used for promoting sleep regulation, and 
regarded as the active ingredients responsible for their 
therapeutic effects (Wang et al., 2008). Modern clinical 
studies have showed that suanzaoren, (Semen ziziphi 
spinosae), which is the dried seed of Ziziphus jujuba Mill 
var. spinosa (Bunge) Hu ex. H.F. Chou (Rhamnaceae), 
possesses multiple activities such as hypnotic-sedative, 
hypotensive, antihypoxia, antihyperlipidemia, and 
hypothermic effects (Fang, Hao, Zhou, Zhu, Wang, & Song, 
2010). A study indicates that suanzaoren exerts sedative 
effects mediated through GABA-A receptors (Zhao, Li, 
Yang, Li, & Wang, 2006). Triterpene saponin Jujuboside B 
(JuB) (Fig. 2) extracted from suanzaoren is considered to 
be the major pharmacological active compounds 
responsible for insomnia treatment (Yang, 2012). The JuB 
has been shown to modulate sleep disruption in insomniac 
patients, however, its detailed targets mechanism for 
hypnotics function is poorly understood.  
Reconstructing networks of biological system entities 
such as genes, transcription factors, proteins, compounds 
and other regulatory molecules is very important for 
 
Fig. 4. Discrete insomnia network map with a customized visual Cytoscape Web style. Yellow nodes refer to 
the significant ontologies of the insomnia dataset 
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understanding the biological processes. Identifying drug 
targets is a critical step in pharmacology. Recent years, 
network pharmacology has influenced all areas of life 
sciences including that of drug mechanism and 
development, new target discovery (Janga, & Tzakos, 
2009). Efficient identification of drug targets is one of 
major challenges for drug discovery and drug 
development. Computational integration of different 
knowledge sources is a more effective approach and 
wealth of SysBiomics data provides unprecedented 
opportunities for drug target identification (Mestres, 
Gregori-Puigjané, Valverde, & Solé, 2009). In types of 
networks, hubs are functionally important, and networks 
grow according to a preferential attachment model. Based 
on the correlations observed in pharmacological and 
genomic spaces, a computational framework, Cytoscape 
was developed to infer JuB-target interactions in a 
genome-wide scale. We highlight some capabilities of the 
Cytoscape with an exploration of insomnia pathogenesis 
genes, in which we identify a putative gene-drug discovery 
and exploration. In the present investigation, we give an 
illustrative example to show that the potential drug target 
identification problem can be solved effectively by our 
method, which may become an effective strategy for the 
discovery of new drugs for insomnia. 
Materials and methods 
Interaction information was retrieved from NCBI’s 
Entrez Gene in December 2, 2011. Information on 
genes/proteins molecular function, biological processes 
and cellular component is imported from the Gene 
Ontology project; while information on biochemical 
pathways is taken from KEGG. Additional information 
includes links to databases, such as KEGG, Reactome, 
BioCyc, NCI Nature PID, DIP, BIND, HPRD, BioGRID, MINT, 
and Intact, which represent the major repositories of 
interacions from multiple organisms. The associations 
 
Fig. 5. Solid map on huge interactome of insomnia networks, built and visualized with Cytoscape. Edges: 
interactions. Nodes: specific proteins or genes 
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between the diseases and genes were from the OMIM 
(http://www.ncbi.nlm.nih.gov/omim). Cytoscape has 
being developed for reconstruction and visualization of 
networks of insomnia. Nodes (represented as circles) in 
the interactome correspond to genes, and edges 
(connecting lines) represent documented interactions. 
Cytoscape is a desktop Java application and source code 
for Cytoscape 2.8 are available for download from 
http://cytoscape.org. Its default annotations are parsed 
from the GO information available from NCBI 
(http://www.ncbi.nlm.nih.gov/Ftp/). Probably the most 
stable one is the Entrez GeneID, which is the unique 
identifier for a gene in NCBI’s Entrez Gene database. 
Results  
Visualization in Cytoscape 
For pathway visualization and analysis of networks, we 
used open-source Cytoscape version 2.8 software (see Fig. 
1). In Cytoscape, networks are represented as graphs 
where the nodes are the entities (e.g. genes, proteins) and 
the edges their interactions (e.g. reactions). For the 
visualization of mutagenesis in the context of biological 
networks, we developed three different node attribute files 
and two visual style files that can easily be imported into 
Cytoscape. This benchmark was run on a standard desktop 
computer (4GHz Pentium intel with 2GB of memory 
running Windows XP). 
Insomnia multilayer network reconstruction 
Taking the closely-connected and co-expressed 
differentially expressed genes, for the insomnia network 
shown in Fig. 3-5, with 77 nodes and 96 edges. Seven of 
them are significant frequencies in insomnia and are likely 
to be responsible for driving the initiation, progression, or 
maintenance of disease. We find that 7 genes considered 
linked because they had close relationship and suggested 
as novel insomnia susceptibility genes using the Cytoscape 
visualization software. The 7 perturbed genes in the 
network has strong connections to the genes. This is 
indicated by the thick edges between these nodes.  
 
 
Fig. 6. Illustration and visualization of the JuB-insomnia interactome network. This sub network represents 
a co regulated unit containing 25 nodes and 31 edges. The interaction map includes four key genes and their 
neighbouring genes 
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JuB–insomnia network model 
A useful tool to search a network between drugs or 
diseases is also available and the network type could be 
NCBI’s Entrez Gene, KEGG, HPRD target network. Fig. 6 
and 7 denotes the relationship between a JuB and 
insomnia disease, for a JuB network of 25 nodes and 31 
edges. Main pathway information, 4 target-genes is 
observed in the Cytoscape-based network with significant 
P-values. These closely connected and co-expressed 
differentially expressed genes in genome wide networks 
are regarded as the signatures of the JuB underlying 
targets. Regulatory sub-network of target-genes on JuB 
through network pharmacology was constructed, and 
shown in Fig. 8. 
Discussion  
Deciphering the genetic basis of human complex 
diseases is an important goal of biomedical research. With 
the rapid progress of the cross-disciplines, the shift from 
the conceptual disease to the systematic drug-disease 
network is required for deeply understanding the 
molecular basis of mutual interrelationships among drug 
and disease systems. Recently, computational SysBiomics 
approaches have been enhancing our understanding of 
various aspects of complex diseases, including the 
identification of disease-related genes or the system 
mechanisms in diseases (Zhang, Sun, Yang, & Wang, 2012). 
Related methods have been successfully applied for 
analyzing many physiological processes, such as type 2 
diabetes, immunology, breast cancer metastasis and drug 
response (Burga, Casanueva, & Lehner, 2011; Silva-Rocha 
& de Lorenzo, 2011; Ma, Tan, Zhang, Wang, Ding, & Li, 
2010; Telesco, Shih, Jia, & Radhakrishnan, 2011). 
Interaction network models are crucially important for 
disease processes. Many of the important properties of 
 
 
Fig. 7. A schematic displaying genes associated with the JuB-insomnia interactome. Central nodes (Yellow) of 
the interaction network were used to illustrate the gene expression obtained and represents significant change 
in expression. The connections between molecules show molecular interactions identified in the JuB -insomnia 
interactome. Gene expression illustrated in coloured nodes was selected with a p < 0.05 value 
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biological systems emerge as a result of the interactions 
among genes and among their protein products. Genes and 
the proteins they encode participate in gene-gene, 
gene-protein, and protein-protein interactions to mediate 
a wide variety of biological processes. Cytoscape is a 
bioinformatics software platform for visualizing molecular 
interaction networks and integrating these interactions 
with gene expression profiles and other state data. 
Cytoscape that can generate a putative protein-protein 
interaction network for target genomes, make the creation 
of protein-protein interaction network predicting tools 
possible. Its central organizing principle is a network 
graph, with biological entities (e.g. genes, proteins) 
represented as nodes and biological interactions 
represented as edges between nodes. Data are integrated 
with the network using attributes, which map nodes or 
edges to specific data values such as gene expression levels 
or protein functions. These features provide a mechanism 
for expressing relationships between sets of data while 
simultaneously visualizing the integrated results. In our 
study, to illustrate the utility of Cytoscape to researchers 
working with insomnia models, we have used the software 
 
Fig. 8. Regulatory sub-network of target-genes on JuB through network pharmacology. A: LEP; B: HBA1; C: 
SLC6A4; D: MAOA 
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to explore insomnia expression data in the context of 
biological network information. Of note, Cytoscape 
successfully provided us with valuable clues for 
identification of drug-target interactions on a large scale 
and predicted and identified drug-target interactions.  
Insomnia is the most common sleep disturbance with 
difficulty initiating or maintaining sleep, along with 
impaired daytime function (Shimomura, 2010). There is a 
high prevalence of insomnia in a variety of negative 
consequences. A meta-analysis of studies on 
sedative-hypnotics drugs caused a number of side effects, 
including habituation, physical and psychological 
dependency, daytime psychomotor and cognitive 
impairment, daytime drowsiness or anxiety, and rebound 
insomnia upon the abrupt discontinuation of sedative 
hypnotic therapy (Beland et al., 2010). In contrast, JuB, a 
classic natural product, has been efficiently used for 
insomnia relief in Asia, although its mechanism remains 
unclear. The existence of interactions between drugs and 
metabolites suggests a potential way to discover drug 
targets. A promising approach in drug target discovery 
involves the integration of available metabolites data 
through mathematical modelling and data mining. 
Significant work has been done on drug discovery, 
however, few papers were discussed with the metabolic 
network. This study was designed to further elucidate the 
underlying mechanism of JuB on sleep regulation from the 
metabolic pathways in a global view. 
Biological networks analysis of the target metabolites 
from the insomnia is becoming increasingly important for 
assessing inherent network properties in reconstructed 
biochemical reaction networks. At present study, we have 
utilized biological networks approach further to delineate 
insomnia and JuB treatment. Of note, 4 differentially 
expressed genes were observed. LEP (GeneID 3952) 
encodes a protein that is secreted by white adipocytes, and 
which plays a major role in the regulation of body weight 
(Fig. 8 A). This protein, which acts through the leptin 
receptor, functions as part of a signalling pathway that can 
inhibit food intake and/or regulate energy expenditure to 
maintain constancy of the adipose mass. This protein also 
has several endocrine functions, and is involved in the 
regulation of immune and inflammatory responses, 
hematopoiesis, angiogenesis and wound healing. HBA1 
(GeneID 3039) encode ghrelin-obestatin preproprotein, 
which generates ghrelin and obestatin (Fig. 8 B). Ghrelin is 
an endogenous ligand for the growth hormone 
secretagogue receptor and is involved in regulating growth 
hormone release. Obestatin was an endogenous ligand for 
the G protein-coupled receptor GPR39. Recent reports 
show that obestatin is involved in inhibiting thirst and 
anxiety, improving memory, regulating sleep, affecting cell 
proliferation, and increasing the secretion of pancreatic 
juice enzymes. SLC6A4 (GeneID 6532) encodes an integral 
membrane protein that transports the neurotransmitter 
serotonin from synaptic spaces into presynaptic neurons 
(Fig. 8C). The encoded protein terminates the action of 
serotonin and recycles it in a sodium-dependent manner. 
This protein is a target of psychomotor stimulants, such as 
amphetamines and cocaine, and is a member of the 
sodium:neurotransmitter symporter family. A repeat 
length polymorphism in the promoter of this gene has 
been shown to affect depression-susceptibility in people 
experiencing emotional trauma. MAOA (GeneID 4128) 
encodes monoamine oxidase A, an enzyme that degrades 
amine neurotransmitters, such as dopamine, 
norepinephrine, and serotonin (Fig. 8, D). The protein 
localizes to the mitochondrial outer membrane.  
The dominant paradigm in drug discovery is the concept 
of designing maximally selective drug targets. However, 
many effective drugs act via modulation of multitargets 
rather than single targets. Advances in systems biology are 
revealing that integrated network biology and 
polypharmacology holds the promise of expanding the 
current opportunity space for drug targets (Hopkins, 
2008). Identification of drug targets is one of the major 
tasks in drug discovery (Raman, Vashisht, & Chandra, 
2009; Gu, Chen, Li, & Li, 2010). More importantly, our 
methods extend the candidate target proteins to a 
genome-wide scale, which greatly enlarges the number of 
known targets. Our method benefits from current 
knowledge such as the known drug-target interactions, 
which provide us with golden standards for understanding 
drug mechanisms. Topological properties in networks 
reflect certain basic characteristics of biological systems. 
Together with known drug-target interactions, such 
information makes it possible to relate pharmacological 
space with genomic space. Thus, we believe that 
combining the integration of multi-dimensional 
information in pharmacological space and genomic space 
gains advantages in target identification information 
which could help to generate further drug discovery. Drug 
target is a key molecule involved in a particular metabolic 
or signalling pathway that is specific to a disease condition. 
Drugs can be designed to modify the functioning of the 
pathway in the diseased state by inhibiting a key molecule, 
or to enhance the normal pathway by promoting specific 
molecules that may have been affected in the diseased 
state and can influence the whole metabolic system by 
targets. Identification and validation of drug target is the 
essential first step in new drug discovery and 
development. Discovery of drug targets through network 
pharmacology analysis promises to be a useful and novel 
approach in this direction. Therefore, there is a strong 
incentive to develop new methods capable of discovering 
these potential target metabolites efficiently. Of note, we 
have characterized 4 speciﬁc genes relevant for drug 
target discovery and found drug-target interaction 
networks involve receptors, neurotransmitter, enzymes, 
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signal transduction. Further experiments can be done to 
validate these targets. It provided strong evidence that the 
hypnotic effect of JuB occurred at the level of global 
network. 
In the results, we demonstrated the usefulness of our 
proposed method for the prediction of the target 
interaction networks. We have constructed the first 
interaction network of the insomnia by using pattern 
recognition approach. These potential targets are 
promising for further experimental validation. Our study 
highlights the importance of network pharmacology as a 
potential tool for uncovering pathways to predict and 
discover drug targets, provide insights into drug action 
mechanisms and enable us to increase research 
productivity throughout the drug discovery and 
development process.  
Conclusions  
System networks that are a central paradigm in biology 
will help us in identifying new drug targets which in turn 
will generate more in-depth understanding of the 
mechanism of diseases and thus provide better guidance 
for drug discovery. Thus network-based pharmacology is 
emerging as an important paradigm for analysis of 
biological systems. A major strength of visualizing gene 
expression data layered onto interaction networks is that 
the networks contain large numbers of molecular 
relationships. Novel relationships between groups of 
co-regulated molecules can be rapidly identified, 
frequently linked through molecules that are not 
differentially expressed but nevertheless are important 
components of the overall functional network. In this 
paper, we present an integrated approach to predict 
targets for approved anti-insomnia JuB by exploring 
network pharmacology. Insomnia networks from our 
analysis were constructed with the aid of Cytoscape 
software. It also implies the significant contribution of 
network to predict drug targets. Finally, we apply our 
method to predict new and possible targets for insomnia 
and JuB drug. Analyzing the topology of the network, we 
have detected 4 potential drug targets and predicted the 
major interactome network of insomnia by using validated 
Cyoscape method. The identified targets were found to 
encompass a variety of pathways related to the HBA1, LEP, 
SLC6A4 and MAOA. Perturbed genes tend to be highly 
coexpressed and functionally coherent and we have used 
this property for predicting drug targets and associating 
novel functions to drug. Through networks analysis, the 
predicted targets may be involved in insomnia-associated 
biological networks. Indeed, future studies in human 
populations with insomnia will be needed to validate the 
biomarkers. Our findings also show that JuB exhibited 
preventive efficacy against insomnia by adjusting multiple 
pathways to their normal state, may be mediated through 
receptor, neurotransmitter, enzymes, and signal 
transduction. Thus, in practice, the integration involves the 
mapping to the nodes of insomnia network and the 
mapping of their functional effect to the edges of a 
network, for their use in the visualization and dynamic 
analysis. We expect that this approach will help in the 
study of the functional impact of insomnia-associated 
pathways, which ultimately will lead to a better 
understanding of the mechanisms underlying complex 
diseases. 
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